Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Health Insurance Innovations Inc    HIIQ

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Health Insurance Innovations, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2017 | 12:32am CET

Levi & Korsinsky announces it has commenced an investigation of Health Insurance Innovations, Inc. (“Health Insurance” or the “Company”) (NASDAQ:HIIQ) concerning possible violations of federal securities laws.

On September 11, 2017, an article was published on Seeking Alpha alleging, among other allegations, that: (1) in June 2017, one of the Company’s key license applications was rejected after regulators uncovered undisclosed legal actions against Company insiders; and (2) the Company privately warned a Florida regulator that a rejection of its license application could create a “domino effect” whereby licensing denials would spread to the other states. Following this news, shares of Health Insurance fell more than 18% to close at $23.35 per share on September 11, 2017. To obtain additional information, go to:

http://www.zlkdocs.com/HIIQ-Info-Request-Form-6098

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HEALTH INSURANCE INNOVATIO
11/16 HEALTH INSURANCE INNOVATIONS 24 HOUR : Approximately 24 Hours Remain; ClaimsFile..
11/13 HEALTH INSURANCE INNOVATIONS INC : FINAL DEADLINE ALERT - Bronstein, Gewirtz & G..
11/10 HEALTH INSURANCE INNOVATIONS INC : FINAL DEADLINE ALERT - Bronstein, Gewirtz & G..
11/10 HIIQ REMINDER DEADLINE ALERT : The Law Offices of Howard G. Smith Reminds Invest..
11/10 HEALTH INSURANCE INNOVATIONS 24 HOUR : Approximately 24 Hours Remain; ClaimsFile..
11/08 HEALTH INSURANCE INNOVATIONS INC : Levi & Korsinsky, LLP Reminds Investors it Fi..
11/08 HEALTH INSURANCE INNOVATIONS INC : DEADLINE ALERT - Bronstein, Gewirtz & Grossma..
11/08 HEALTH INSURANCE INNOVATIONS 72 HOUR : Approximately 72 Hours Remain; Former Lou..
11/07 HEALTH INSURANCE INNOVATIONS INC : HIIQ The Law Offices of Vincent Wong Reminds ..
11/07 HEALTH INSURANCE INNOVATIONS : Glancy Prongay & Murray Reminds Investors of Loom..
More news
News from SeekingAlpha
11/06 HEALTH INSURANCE INNOVATIONS : Fundamentals Shine
11/02 Health Insurance Innovations' (HIIQ) CEO Gavin Southwell on Q3 2017 Results -..
11/01 Health Insurance Innovations beats by $0.07, beats on revenue
10/31 Notable earnings after Wednesday?s close
10/18 HEALTH INSURANCE INNOVATIONS : Set Aside Debunked Fraud Claims And Focus On Fund..
Financials ($)
Sales 2017 241 M
EBIT 2017 -
Net income 2017 18,1 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 16,55
P/E ratio 2018 14,06
Capi. / Sales 2017 1,64x
Capi. / Sales 2018 1,44x
Capitalization 394 M
Chart HEALTH INSURANCE INNOVATIO
Duration : Period :
Health Insurance Innovatio Technical Analysis Chart | HIIQ | US42225K1060 | 4-Traders
Technical analysis trends HEALTH INSURANCE INNOVATIO
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 37,5 $
Spread / Average Target 58%
EPS Revisions
Managers
NameTitle
Gavin C. Southwell President, Chief Executive Officer & Director
Paul G. Gabos Non-Executive Chairman
Michael D. Hershberger CFO, Secretary, Treasurer & CAO
Sheldon X. Wang Chief Technology Officer & Director
Michael W. Kosloske Director & Chief-Product Innovation
Sector and Competitors